PCN71 COST-EFFECTIVENESS OF RITUXIMAB COMBINED WITH FLUDARABINE AND CYCLOPHOSPHAMIDE IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN FRANCE
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74322-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)74322-9/fulltext
Title :
PCN71 COST-EFFECTIVENESS OF RITUXIMAB COMBINED WITH FLUDARABINE AND CYCLOPHOSPHAMIDE IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN FRANCE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74322-9&doi=10.1016/S1098-3015(10)74322-9
First page :
Section Title :
Open access? :
No
Section Order :
248